USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

Market Overview ScreenersIndustriesCompanies Community Investment Grader

US Market Open: Feb 9, 16:11 PM 2012

NYSE 8080.13 2.85 Index Moved Down

NASDAQ 2927.23 11.37 Index Moved Up

and more..

sponsered by

Processing
Collecting necessary data for ALKS and NKTR...

Asset Comparison and Correlation

View All Portfolios

More Actions
- Select Assests
- Optimize Portfolio
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatilities
- Import Equities
- Search Equities
- Filter Tops

Alkermes Inc. and

Nektar Therapeutics

Volatility

Matrix

Run Correlation

Diversification

Weak diversification

Overlapping area represents amount of risk that can be diversified away by holding Alkermes Inc. and Nektar Therapeutics in the same portfolio (assuming nothing else is changed)

Optimize

Correlation Coefficient

0.34

Parameters

Time Period	1 Month [change]
Direction	Positive
Strength	Very Weak
Accuracy	95.83%
Values	Daily Returns

Suggest

Alkermes Inc.

Profile

18.46

Intraday

One Month

^(0.42)

2.22%

ALKS

NASDAQ

Alkermes Inc.

Day Low	18.45	Open	19.04
P/B Ratio	2.71	Market Cap	2.395B
Volume	511827	Sector	Healthcare
Last Close	18.88	Founded	Yes
Short Ratio	7.60	Last Traded	2/9/2012
Year High	20.00	Percent Change	2.22%
EBITDA	12.2M	Year Low	11.86
Absolute Change	0.42	Time	Not Applicable
Book Value	6.974	EPS	-0.60
PEG Ratio	0.13	Employees	600
Day High	19.05	Industry	Drug Delivery
Target Price	21.90	Current EPS	-0.60
This Year EPS	-0.62	Next Year EPS	-0.28

Nektar Therapeutics

Profile

6.98

Intraday

One Month

^(0.23)

3.19%

NKTR

NASDAQ

Nektar Therapeutics

Day Low	6.97	Open	7.19
P/B Ratio	3.57	Market Cap	798.7M
Volume	756626	Sector	Healthcare
Last Close	7.21	Founded	Yes
Short Ratio	14.90	Last Traded	2/9/2012
Year High	11.25	Percent Change	3.19%
EBITDA	-82.0M	Year Low	4.07
Absolute Change	0.23	Time	Not Applicable
Book Value	2.017	EPS	-1.103
Employees	408	Day High	7.35
Target Price	10.67	Current EPS	-1.103
This Year EPS	-1.33	Next Year EPS	-1.38